1040-8711
Published by: Lippincott Williams & Wilkins
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Immunology | 96 | 37 | 54 | 18 |
| Medicine | 903 | 80 | 106 | 25 |
Current Opinion in Rheumatology was organized to reinforce research efforts on Immunology, Disease, Arthritis, Intensive care medicine and Internal medicine. Pathogenesis, Immune system, Autoantibody, Autoimmunity and Inflammation are some of the facets of Immunology tackled in it. In Current Opinion in Rheumatology, Epidemiology, Scleroderma and Bioinformatics are investigated in conjunction with one another to address concerns in Disease research.
Dermatology and Rheumatoid arthritis are some topics wherein Arthritis research discussed in Current Opinion in Rheumatology have an impact. It explores topics in Intensive care medicine which can be helpful for research in disciplines like Clinical trial and MEDLINE. Discussions in the journal are anchored in the subject of MEDLINE and the similar topic of Physical therapy.
Current Opinion in Rheumatology explores research in Physical therapy and the adjacent study of Osteoarthritis. The journal focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology, Endocrinology and Oncology.
Immunology, Disease, Arthritis, Rheumatoid arthritis and Pathology are the main subjects of interest in the most cited papers. Aside from discussions in Disease, the most cited publications also deal with the subject of Intensive care medicine which intersects with Physical therapy disciplines. The Arthritis research presented in the most cited papers focuses mostly on MEDLINE and, on occasion, topics in Osteoarthritis.
The journal explores disciplines such as Disease, Intensive care medicine, Immunology, Internal medicine and Pathogenesis. Some problems in Disease that were presented in the journal overlapped with concepts under Scleroderma, Pathological, Rheumatoid arthritis and Bioinformatics. While Intensive care medicine is the focus of Current Opinion in Rheumatology, it also provided insights into the studies of Clinical trial, MEDLINE, Coronavirus disease 2019 (COVID-19), Referral and Back pain.
Autoantibody, Immune system, Inflammation, T cell and Autoimmunity are among the areas of Immunology tackled. The study of Oncology and how it intertwines with concepts under Tocilizumab were explored in the presented Internal medicine research. The presented Pathogenesis research focuses mostly on Cytokine and, on occasion, topics in Cytotoxic T cell.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Current Opinion in Rheumatology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Current Opinion in Rheumatology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.41% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 27.40% were posted by at least one author from the top 10 institutions publishing in the journal. Another 23.29% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.70% of all publications and 35.62% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Yu Liu;Amr H. Sawalha;Qianjin Lu;Qianjin Lu
(2021)Chio Yokose;Natalie McCormick;Hyon K Choi
(2021)Frédéric Coutant;Pierre Miossec
(2020)Hao Li;George C. Tsokos
(2021)Alain Lescoat;Valérie Lecureur;John Varga
(2021)Erica Moore;Michelle W. Huang;Chaim Putterman;Chaim Putterman
(2020)Patricia Katz;Brian J Andonian;Kim M Huffman
(2020)For those interested in studying Medicine in the USA, numerous related online degrees and career pathways exist within the healthcare field. One popular option is becoming a Nurse Practitioner, a role that offers advanced clinical responsibilities. Understanding how long does it take to become a nurse practitioner is essential for planning your educational journey efficiently.
Many registered nurses look to expand their qualifications through accelerated programs. For example, the 6-month rn to bsn program online options allow nurses to earn their Bachelor of Science in Nursing degree quickly while managing work and personal commitments. This can be a crucial step for career advancement or specialization.
Additionally, bridge programs like adn to np programs provide an efficient path for those with an Associate Degree in Nursing to become Nurse Practitioners. These programs combine coursework and clinical experience to equip students with the skills needed for advanced practice roles.
For individuals without a nursing background, there are msn direct entry programs online. These accelerated pathways offer a chance to enter nursing at the master’s level, preparing students for leadership and healthcare provider roles, often in less time than traditional programs.
